ESC Premium Access

PFO closure for cryptogenic stroke – Represented in NEJM by the CLOSURE I, PC, REDUCE, CLOSE, and RESPECT trials

Topic: Coronary Artery Disease (Chronic) / Chronic Coronary Syndromes (CCS)

Congress Presentation

About the speaker

Professor Lars Soendergaard

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)
15 presentations

3 more presentations in this session

Antithrombotic therapy in stable cardiovascular disease - Represented in NEJM by the COMPASS trial and the PEGASUS-TIMI 54 trial

Speaker: Doctor J. Eikelboom (Hamilton, CA)


Antithrombotic therapy in patients with atrial fibrillation undergoing PCI – Represented in NEJM by the PIONEER-AF PCI trial and the RE-DUAL PCI trial

Speaker: Professor C. Cannon (Boston, US)


Fractional Flow Reserve-Guided PCI – represented in NEJM by the FAME, FAME-2, Compare-Acute, IFR-SWEDEHEART, and DEFINE-FLAIR trials

Speaker: Professor E. Barbato (Rome, IT)


Access the full session

Highlights from the New England Journal of Medicine: Editors’ Choice

Speakers: Professor L. Soendergaard, Doctor J. Eikelboom, Professor C. Cannon, Professor E. Barbato

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb